RxDoctor Payments Data

Emily Little, PA

Medical · Columbus, GANPI 1891046694

Payments from drug & device makers

$8,248in general payments, 2019–2025

Across 449 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • Johnson & Johnson$628
  • Ardelyx, Inc.$420
  • Ironwood Pharmaceuticals, Inc$274
  • Intercept Pharmaceuticals, Inc.$253
  • plus $3K from 24 others

What the payments were for

  • Food & beverage$8,228100%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,248 in reported general payments places this provider in the 90th percentile of 950 medical providers in Georgia.

See all medical providers in Georgia

Medicare billing

Part B allowed, 2024
$51,069
Medicare patients
501
Services billed
564

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide112$133,652
Humira(Cf) PenAdalimumab13$92,694
TrulancePlecanatide17$22,726
Mesalamine15$8,450
Dexlansoprazole DrDexlansoprazole17$4,741
Sucralfate53$4,213
Pantoprazole Sodium322$3,392
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C20$2,850
Budesonide DrBudesonide12$1,893
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl90$1,471
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl84$1,448
Omeprazole106$1,146
Esomeprazole Magnesium20$1,074
Dicyclomine Hcl64$948
Famotidine75$938

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$2,283$133,652112 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance, Plenvu$1,863$25,57737 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 950 medical providers in Georgia.

Other medical in Columbus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →